Grantham, Mayo, Van Otterloo & Co (GMO)
NXTM

Grantham, Mayo, Van Otterloo & Co (GMO)’s NxStage Medical Inc. NXTM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-232,100
Closed -$6.64M – 770
2018
Q4 		$6.64M Sell
232,100
-270,200
-54% -$7.68M 0.05% 168
2018
Q3 		$14M Sell
502,300
-514,540
-51% -$14.5M 0.09% 126
2018
Q2 		$28.4M Sell
1,016,840
-406,365
-29% -$10.9M 0.2% 77
2018
Q1 		$35.4M Buy
1,423,205
+238,455
+20% +$5.8M 0.22% 78
2017
Q4 		$28.7M Buy
1,184,750
+152,250
+15% +$4.01M 0.17% 89
2017
Q3 		$28.5M Buy
+1,032,500
New +$27.5M 0.17% 99

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NXTM Position: Q1 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 232,100 shares — an estimated $6.64M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $35.4M in Q1 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 232,100 NxStage Medical Inc. shares in Q1 2019, an estimated $6.64M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s NxStage Medical Inc. position peaked at $35.4M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2019, filed 14 May 2019.